We next assessed p190A protein levels in a tissue microarray composed of BC patient samples at different pathological stages in order to comprehend the association of p190A levels with the clinical progression and outcomes of BC using immunohistochemical (IHC) staining (Fig. 2A). Here, ARHGAP35 is linked to breast cancer.